NO931709D0 - Nukleinsyreamplifisering ved hjelp av to-enzymers, selvunderholdende sekvensreplikasjon - Google Patents

Nukleinsyreamplifisering ved hjelp av to-enzymers, selvunderholdende sekvensreplikasjon

Info

Publication number
NO931709D0
NO931709D0 NO931709A NO931709A NO931709D0 NO 931709 D0 NO931709 D0 NO 931709D0 NO 931709 A NO931709 A NO 931709A NO 931709 A NO931709 A NO 931709A NO 931709 D0 NO931709 D0 NO 931709D0
Authority
NO
Norway
Prior art keywords
enzymers
self
nucleic acid
acid amplification
sequence replication
Prior art date
Application number
NO931709A
Other languages
English (en)
Other versions
NO931709L (no
Inventor
Eoin David Fahy
Deborah Yantis Kwoh
Thomas Raymond Gingeras
Original Assignee
Siska Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siska Diagnostics Inc filed Critical Siska Diagnostics Inc
Publication of NO931709D0 publication Critical patent/NO931709D0/no
Publication of NO931709L publication Critical patent/NO931709L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
NO93931709A 1990-11-13 1993-05-11 Nukleinsyreamplifisering ved hjelp av to-enzymers, selvunderholdende sekvensreplikasjon NO931709L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61268890A 1990-11-13 1990-11-13
PCT/US1991/008488 WO1992008800A1 (en) 1990-11-13 1991-11-13 Nucleic acid amplification by two-enzyme, self-sustained sequence replication

Publications (2)

Publication Number Publication Date
NO931709D0 true NO931709D0 (no) 1993-05-11
NO931709L NO931709L (no) 1993-07-12

Family

ID=24454235

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93931709A NO931709L (no) 1990-11-13 1993-05-11 Nukleinsyreamplifisering ved hjelp av to-enzymers, selvunderholdende sekvensreplikasjon

Country Status (13)

Country Link
EP (1) EP0572417A4 (no)
JP (1) JPH06502767A (no)
AU (1) AU9131591A (no)
CA (1) CA2096013A1 (no)
FI (1) FI932144A0 (no)
HU (1) HUT69772A (no)
IE (1) IE913930A1 (no)
IL (1) IL100040A (no)
NO (1) NO931709L (no)
NZ (1) NZ240574A (no)
PT (1) PT99500A (no)
WO (1) WO1992008800A1 (no)
ZA (1) ZA918965B (no)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0628076A1 (en) * 1992-11-19 1994-12-14 GINGERAS, Thomas R. PRODUCTION OF MONOCLONAL RECOMBINANT ANTIBODIES WITHOUT THE USE OF HYBRIDOMAS BY $i(IN VITRO) SPLEEN FRAGMENT CULTURE COMBINED WITH ISOTHERMAL SELF-SUSTAINED SEQUENCE REPLICATION OF RNA
EP1251182A3 (en) * 1993-12-01 2002-11-27 Toyo Boseki Kabushiki Kaisha Method of amplifying and detecting target nucleic acid sequence by using thermostable enzymes
US5705366A (en) * 1994-09-15 1998-01-06 Johnson & Johnson Clinical Diagnostics, Inc. Coamplification of target nucleic acids using volume exclusion agent in reaction composition, test kit and test device useful therefor
JPH08131171A (ja) * 1994-11-11 1996-05-28 Asahi Chem Ind Co Ltd 逆転写酵素の安定化組成物
US5763184A (en) 1996-01-30 1998-06-09 Roche Molecular Systems, Inc. Nucleotide sequence variation in the ABO glycosyltransferase gene
AU4515699A (en) * 1998-06-26 2000-01-17 Akzo Nobel N.V. Tagging of rna amplicons generated by transcription-based amplification
JP2001029078A (ja) * 1999-07-16 2001-02-06 Shimadzu Corp Ｒｎａ増幅法
WO2002012263A1 (en) 2000-08-03 2002-02-14 Roche Diagnostics Gmbh Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses
US6780588B2 (en) 2001-05-07 2004-08-24 Applera Corporation Methods for the reduction of stutter in microsatellite amplification
US6841349B2 (en) 2001-05-07 2005-01-11 Applera Corporation Applied Biosystems Group Methods for the reduction of stutter in microsatellite amplification
US9777312B2 (en) 2001-06-30 2017-10-03 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
US9261460B2 (en) 2002-03-12 2016-02-16 Enzo Life Sciences, Inc. Real-time nucleic acid detection processes and compositions
US20040161741A1 (en) 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
WO2003057910A2 (en) 2002-01-08 2003-07-17 Roche Diagnostics Gmbh Use of silica material in an amplification reaction
WO2003064679A2 (en) 2002-01-30 2003-08-07 Id Biomedical Corporation Methods for detecting vancomycin-resistant microorganisms and compositions therefor
US9353405B2 (en) 2002-03-12 2016-05-31 Enzo Life Sciences, Inc. Optimized real time nucleic acid detection processes
DE10240868A1 (de) * 2002-09-04 2004-03-18 Artus Gesellschaft für molekularbiologische Diagnostik und Entwicklung mbH Verbesserte Verfahren zur Synthese von Nukleinsäuren
WO2004067545A1 (en) 2003-01-29 2004-08-12 Roche Diagnostics Gmbh Improved method for bisulfite treatment
JP2004357502A (ja) * 2003-05-30 2004-12-24 Olympus Corp 核酸分子を使用した情報処理方法
EP1767655A4 (en) 2004-07-13 2007-08-01 Takeda Pharmaceutical METHOD FOR CONTROLLING CELL FUCTIONS
EP1632578A1 (en) 2004-09-03 2006-03-08 Roche Diagnostics GmbH DNA decontamination method
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
CA2694832A1 (en) 2007-08-06 2009-02-12 Orion Genomics Llc Novel single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the igf2 gene
CA2639416C (en) 2007-09-11 2019-12-31 F. Hoffmann-La Roche Ag Diagnostic test for susceptibility to b-raf kinase inhibitors
EP2217720A4 (en) 2007-11-01 2010-12-08 Univ Iowa Res Found RNA LOCUS ANALYSIS TO ASSESS THE STUNNING FOR AMD AND MPGNII
WO2010093820A2 (en) 2009-02-11 2010-08-19 Orion Genomics Llc Combinations of polymorphisms for determining allele-specific expression of igf2
WO2011128096A1 (en) 2010-04-16 2011-10-20 Roche Diagnostics Gmbh Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
CA2801468C (en) 2010-06-04 2018-09-04 Chronix Biomedical Prostate cancer associated circulating nucleic acid biomarkers
WO2012040619A2 (en) 2010-09-24 2012-03-29 Massachusetts Eye And Ear Infirmary Methods and compositions for prognosing and/or detecting age-related macular degeneration
US9458484B2 (en) 2010-10-22 2016-10-04 Bio-Rad Laboratories, Inc. Reverse transcriptase mixtures with improved storage stability
MX2014002307A (es) 2011-08-31 2014-08-26 Hoffmann La Roche Metodo para predecir el riesgo de hipertension asociado a la terapia antiangiogenesis.
MX2014002311A (es) 2011-08-31 2014-08-26 Hoffmann La Roche Capacidad de respuesta a inhibidores de angiogenesis.
AU2012312515A1 (en) 2011-09-19 2014-03-13 Genentech, Inc. Combination treatments comprising c-met antagonists and B-raf antagonists
CA2852098C (en) 2011-10-21 2023-05-02 Chronix Biomedical Colorectal cancer associated circulating nucleic acid biomarkers
CN104066852A (zh) 2011-11-23 2014-09-24 霍夫曼-拉罗奇有限公司 对血管发生抑制剂的响应性
US9115394B2 (en) 2011-12-22 2015-08-25 Roche Molecular Systems, Inc. Methods and reagents for reducing non-specific amplification
DK3004388T4 (da) 2013-05-29 2023-08-28 Chronix Biomedical Påvisning og kvantificering af cellefrit dna fra donor i kredsløbet hos organtransplantatmodtagere
SG11201607772WA (en) 2014-03-31 2016-10-28 Debiopharm Int Sa Fgfr fusions
CN107109494B (zh) 2014-11-10 2023-10-27 豪夫迈·罗氏有限公司 Il-33介导型疾病的治疗方法和诊断方法
AU2016252998B2 (en) 2015-04-24 2021-11-04 Atila Biosystems Incorporated Amplification with primers of limited nucleotide composition
HUE044698T2 (hu) 2015-08-17 2019-11-28 Kura Oncology Inc Kezelési módszer rákos páciensek kezelésére farnezil-transzferáz inhibitorokkal
WO2017184968A1 (en) 2016-04-22 2017-10-26 Kura Oncology, Inc. Methods of selecting cancer patients for treatment with farnesyltransferase inhibitors
JP2019534290A (ja) 2016-11-03 2019-11-28 クラ オンコロジー， インコーポレイテッド 癌の治療方法において使用するためのファルネシルトランスフェラーゼ阻害剤
US9956215B1 (en) 2017-02-21 2018-05-01 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
EP4119142A1 (en) 2017-02-21 2023-01-18 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
MY200746A (en) 2017-08-07 2024-01-13 Kura Oncology Inc Methods of treating cancer with farnesyltransferase inhibitors
US10806730B2 (en) 2017-08-07 2020-10-20 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
AU2019218128A1 (en) 2018-02-09 2020-09-17 Genentech, Inc. Therapeutic and diagnostic methods for mast cell-mediated inflammatory diseases
TW202031259A (zh) 2018-11-01 2020-09-01 美商庫拉腫瘤技術股份有限公司 以法尼基轉移酶(farnesyltransferase)抑制劑治療癌症之方法
WO2020180663A1 (en) 2019-03-01 2020-09-10 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
AU2020254492A1 (en) 2019-03-29 2021-11-11 Kura Oncology, Inc. Methods of treating Squamous Cell Carcinomas with farnesyltransferase inhibitors
WO2020205387A1 (en) 2019-04-01 2020-10-08 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
WO2020223583A1 (en) 2019-05-02 2020-11-05 Kura Oncology, Inc. Methods of treating acute myeloid leukemia with farnesyltransferase inhibitors
JP2023516497A (ja) 2020-03-13 2023-04-19 メドイミューン・リミテッド Ｉｌ３３にリスクアレルを有する対象を治療するための治療方法
WO2024015331A1 (en) 2022-07-12 2024-01-18 Genentech, Inc. Therapeutic and diagnostic methods for multiple sclerosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800159A (en) * 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
CA1340807C (en) * 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
CA2005589C (en) * 1988-12-16 2001-02-06 Akzo Nobel Nv Self-sustained, sequence replication system
FI911152A7 (fi) * 1989-07-11 1991-03-07 Gen Probe Inc Nukleiinihapposekvenssin amplifikaatiomenetelmät

Also Published As

Publication number Publication date
IL100040A (en) 1995-12-31
HU9301369D0 (en) 1993-10-28
AU9131591A (en) 1992-06-11
FI932144L (fi) 1993-05-12
NO931709L (no) 1993-07-12
PT99500A (pt) 1992-10-30
FI932144A7 (fi) 1993-05-12
EP0572417A4 (en) 1994-11-23
FI932144A0 (fi) 1993-05-12
EP0572417A1 (en) 1993-12-08
IL100040A0 (en) 1992-08-18
NZ240574A (en) 1994-10-26
HUT69772A (en) 1995-09-28
CA2096013A1 (en) 1992-05-14
IE913930A1 (en) 1992-06-17
WO1992008800A1 (en) 1992-05-29
ZA918965B (en) 1992-08-26
JPH06502767A (ja) 1994-03-31

Similar Documents

Publication Publication Date Title
NO931709D0 (no) Nukleinsyreamplifisering ved hjelp av to-enzymers, selvunderholdende sekvensreplikasjon
DE3884094D1 (de) Kinderwagen.
DE69015008D1 (de) Handwagen.
FI880428A0 (fi) Ytantigener av hepatit b virus och hybridantigener innehaollande desamma.
NO904634L (no) Amplifikasjon av nukleinsyre ved anvendelse av ligerbare,haarnaalsprobe og transkripsjon.
DE3879627D1 (de) Huellkurvenverstaerker.
DE69102210D1 (de) Optischer Mehrstufenverstärker.
FI880383A7 (fi) Transformation och expression av en fraemmande gen i brassicaarter.
FI885504L (fi) Vaskulaera antikoagulerande proteiner, dessa koderande dna, deras framstaellningsfoerfarande och deras anvaendning.
FI885735L (fi) System foer godstransport, vilka aer transformerbara till jaernvaegsfordon och med systemet anvaendbara boggier.
FI913678A0 (fi) Anordning foer modulering av avsoekningshastigheten, vilken anordning aer foersedd med en spaerrkrets.
FI883352L (fi) Anvaendning av dubbelstraengad rna foer framstaellning av ett laekemedel foer behandling av inflammationer.
FI885581A7 (fi) Anordning foer mottagning, transportering, foerminskning och frammatning av foderblock.
NO903937D0 (no) Oksydasjonsreaktor.
FI895593A0 (fi) Anordning i synnerhet foer behandling av kraemer och pastor.
FI890874L (fi) Expression av hiv-bindningsproteiner.
FI883005L (fi) Promotorer foer expression av fraemmande dna i metylotrofiska bakterier, deras tillvaratagande och deras anvaendning.
FI881434A0 (fi) Foerfarande foer framstaellning av imidazopyridinderivat vilka aer terapeutiskt anvaendbara.
FI885707A0 (fi) Foerfarande foer frihaollning av genomstroemningskanalen till en staonggjutmaskins glidlucka.
FI890116L (fi) Icke-reverterande rna-virus.
FI881695L (fi) Foerfarande foer bestaemning av laengdskillnaden mellan en optisk ledares fiber och en optisk ledares mantel.
FI914149L (fi) Foerfarande foer kontinuerlig omsaettning av kefalosporinderivat till glutaryl-7-aminokefalosporinsyraderivat.
FI882634A7 (fi) Pressvals, vars boejning aer instaellbar.
DE3879124D1 (de) Erhitzer.
DE3850923D1 (de) Operationsverstärkerstufen.